Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PDS Biotechnology Corp (EDGE)
|
Add to portfolio |
|
|
|
| Price: |
$5.29
| | Metrics |
| OS: |
30.9
|
M
| |
|
|
| Market cap: |
$163
|
M
| |
|
|
|
Net cash:
|
$37.4
|
M
| |
$1.21
|
per share
|
|
EV:
|
$126
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($29.2)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 11.3 | 7.9 | 6.1 | 0.8 | 34.3 | 24.8 | 17.8 | 8.5 |
| General and administrative | 10.2 | 7.0 | 11.0 | 2.8 | 17.7 | 14.7 | 8.7 | 4.7 |
| EBIT | -21.4 | -14.9 | -18.1 | -3.6 | -52.0 | -39.5 | -26.5 | -13.2 |
| Pre-tax income | -21.4 | -14.8 | -7.4 | -3.8 | -53.4 | -40.7 | -29.2 | -12.8 |
| Income taxes | -4.5 | 0.0 | -0.4 | 0.0 | -2.6 | -1.8 | -1.1 | -0.6 |
| Tax rate | 21.1% | 0.0% | 5.2% | 0.0% | 4.8% | 4.5% | 3.8% | 4.6% |
| Net income | -16.9 | -14.8 | -7.0 | -3.8 | -50.9 | -38.8 | -32.4 | -13.8 |
| |
| Diluted EPS | ($0.66) | ($0.89) | ($1.44) | ($1.15) | ($1.67) | ($1.34) | ($4.01) | ($8.16) |
| Shares outstanding (diluted) | 25.6 | 16.7 | 4.9 | 3.3 | 30.4 | 28.9 | 8.1 | 1.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|